Buscar
Mostrando ítems 1-10 de 12
The Importance of Understanding the Stages of COVID-19 in Treatment and Trials
(AIDS reviews, 2021)
COVID-19, caused by SARS-CoV-2, continues to be a major health problem since its first description in Wuhan, China, in December 2019. Multiple drugs have been tried to date in the treatment of COVID-19. Critical to treatment ...
Situación epidemiológica actual de la infección por VIH-2 y HTLV-1 en España
(Medicina clinica, 2021)
La familia Retroviridae incluye 7 subfamilias. Los miembros de
2 de ellas infectan a humanos y son patogénicos. Se trata de los
deltarretrovirus, de los cuales el human T-cell lymphotropic virus
(HTLV, «virus linfotrópico ...
Clinical Outcome in Human T-Lymphotropic Virus Type 2 Carriers Following Organ Transplantation
(Transplantation proceedings, 2021)
Background
Frequent and rapid development of myelopathy has been reported in individuals with human T-lymphotropic virus type 1 (HTLV-1) infection following solid organ transplantation. There is no information regarding ...
Main differences between the first and second waves of COVID-19 in Madrid, Spain
(International journal of infectious diseases, 2021)
Background: The emergence and rapid global spread of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) represents a major challenge to health services, and has disrupted social and economic activities worldwide. ...
The time to offer treatments for COVID-19
(Expert opinion on investigational drugs, 2021)
Background: COVID-19 has several overlapping phases. Treatments to date have focused on the late stage of disease in hospital. Yet, the pandemic is by propagated by the viral phase in out-patients. The current public health ...
Third wave of COVID-19 in Madrid, Spain
(Innoeduca-international journal of infectious diseases, 2021)
A third wave of COVID-19 occurred after Christmas 2020 in Madrid, one of the European pandemic epicenters. We noticed 6 major differential features to previous waves. First, household contacts were a large proportion of ...
Development of the HIV360 international core set of outcome measures for adults living with HIV: A consensus process
(John Wiley and Sons Inc, 2021)
Objectives: HIV outcomes centre primarily around clinical markers with limited focus on patient-reported outcomes. With a global trend towards capturing the outcomes that matter most to patients, there is agreement that ...
Short Communication: Impact of COVID-19 on Case Reporting for HTLV and HIV-2 in Spain
(Mary Ann Liebert Inc., 2021)
The medical demand imposed by COVID-19 has distracted proper care of other illnesses. Herein, we report the impact on new diagnoses of HTLV-1, HTLV-2, and HIV-2 in Spain, where these infections are mostly driven by immigration ...
Hepatitis C Treatment Outcomes in Persons With HIV and Decompensated Cirrhosis Using a Collaborative Multidisciplinary HIV-Centered Approach
(SAGE Publications Inc., 2021)
Fifty-four consecutive persons with HIV co-infected with hepatitis C virus (HCV) and liver decompensation were treated with direct-acting antivirals (DAA). The HCV treatment was delivered using a multidisciplinary ...
Envisioning a hepatitis delta cure with new antivirals
(Future Medicine Ltd., 2021)
Envisioning a hepatitis delta cure with new antivirals
